Assure Neuromonitoring
Healthcare Services · Colorado, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
7887 E Belleview Ave Ste 240, Denver, Co...Phone Number
(720) 287-3093Revenue
<$5 MillionStock Symbol
IONMIndustry
About Assure Neuromonitoring
Assure Neuromonitoring Org Chart
Is Assure Neuromonitoring your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Assure Neuromonitoring recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Assure Neuromonitoring has recently received funding, and reach out quickly before it becomes old news!
Check out if Assure Neuromonitoring is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Assure Neuromonitoring
Funding: Get notified immidiatlly once Assure Neuromonitoring has new funding data
Product Launch: Get notified when Assure Neuromonitoring launches new products
Assure Neuromonitoring, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Assure Neuromonitoring had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Assure Neuromonitoring as Masked Content
Find more new buyers
Compare Similar Companies to Assure Neuromonitoring
Compare insights from companies similar to Assure Neuromonitoring, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Assure Neuromonitoring is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Assure Neuromonitoring is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Assure Neuromonitoring.
Assure Neuromonitoring financials insights
Gather financial insights about Assure Neuromonitoring, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$3.1M
Debt
$1M
Debt
$1.7M
Assure Neuromonitoring Tech Stack
A closer look at the technologies used by Assure Neuromonitoring
Most Recent Scoops
Assure Neuromonitoring News & Media
Assure Announces Further Extension of Exchange Offer Relating to its Convertible Notes
DENVER, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (“Assure” or the “Company”) (OTC: IONM), today announced that it has extended the expiration date of its exchange offer (the “Offer”) relating to the Company’s 9% Convertible Debentures due 2023 and 2024 (the “Assure Convertible Debentures”). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on September 6, 2024 (the “Expiration Date”) unless further extended.Assure Announces Further Extension of Exchange Offer Relating to its Convertible Notes
Assure Announces Further Extension of Exchange Offer Relating to its Convertible NotesAssure Announces Further Extension of Exchange Offer Relating to its Convertible Notes
DENVER, July 29, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (“Assure” or the “Company”) (NASDAQ: IONM), today announced that it has extended the expiration date of its exchange offer (the “Offer”) relating to the Company’s 9% Convertible Debentures due 2023 and 2024 (the “Assure Convertible Debentures”). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on August 2, 2024 (the “Expiration Date”) unless further extended.Assure Announces Extension of Exchange Offer Relating to its Convertible Notes
DENVER, July 22, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (“Assure” or the “Company”) (NASDAQ: IONM), today announced that it has extended the expiration date of its exchange offer (the “Offer”) relating to the Company’s 9% Convertible Debentures due 2023 and 2024 (the “Assure Convertible Debentures”). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on July 26, 2024 (the “Expiration Date”) unless further extended.
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Assure Neuromonitoring
Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of i... Read More